(Q38452776)

English

Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda

scientific article published on 17 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda (English)

1 reference

Europe PubMed Central

3 September 2017

0 references

Schistosoma mansoni

0 references

1 reference

based on heuristic

inferred from title

Edridah M Tukahebwa

1

object named as

Edridah M Tukahebwa

1 reference

Europe PubMed Central

3 September 2017

Narcis B Kabatereine

4

object named as

Narcis B Kabatereine

1 reference

Europe PubMed Central

3 September 2017

Birgitte J Vennervald

object named as

Birgitte J Vennervald

2

0 references

Pascal Magnussen

object named as

Pascal Magnussen

5

0 references

3

object named as

Fred Nuwaha

1 reference

Europe PubMed Central

3 September 2017

publication date

17 April 2013

1 reference

Europe PubMed Central

3 September 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

3 September 2017

107

1 reference

Europe PubMed Central

3 September 2017

6

1 reference

Europe PubMed Central

3 September 2017

397-404

1 reference

Europe PubMed Central

3 September 2017

Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

An international initiative on praziquantel use.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

The efficacy of praziquantel against Schistosoma mansoni infection in Ndombo, northern Senegal

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Morbidity in schistosomiasis: an update

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

The impact of chemotherapy on morbidity due to schistosomiasis

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Schistosoma mansoni morbidity among adults in two villages along Lake Victoria shores in Mwanza District, Tanzania

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT024

21 January 2018

Identifiers

10.1093/TRSTMH/TRT024

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38452776&oldid=1760308645"